Cystoscopy
Cystoscopy 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Muscle Invasive Bladder Urothelial Carcinoma、Muscle Invasive Renal Pelvis Urothelial Carcinoma、Muscle Invasive Ureter Urothelial Carcinoma、Muscle Invasive Urethral Urothelial Carcinoma。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
5 项
已进入 III/IV 期
17 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- National Cancer Institute (NCI)
- Cedars-Sinai Medical Center
- Nucleix Ltd.
- Photocure
- Alliance for Clinical Trials in Oncology
- Mayo Clinic
- Queen Mary Hospital, Hong Kong
- Optheras AS
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
美国、英国、比利时、加拿大、德国、挪威、中国、丹麦、法国、Egypt、澳大利亚、意大利
正在招募患者的 Cystoscopy 研究
Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy
不适用招募中美国NCT04442724Bladder EpiCheck European Haematuria Study
不适用招募中英国NCT06818136Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
不适用招募中美国比利时加拿大德国NCT07144319Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
III 期招募中美国NCT07000084Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
II 期 / III 期招募中美国加拿大NCT05987241MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer
不适用招募中美国NCT05438563PUL vs TURP in BPH Patients With Urinary Retention
不适用招募中中国NCT06037356Feasibility of Automatic, Laser-based Distance Control in Persons With Superficial Bladder Tumors
不适用招募中丹麦NCT07860398MICROBIOTA AND BLADDER CANCER
不适用招募中法国NCT07080333Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-ALA
II 期招募中美国NCT07828704Standardized Prenatal Clinical Care for LUTO
不适用招募中美国NCT02315521Comparison Between Two Methods for Renal Stone Treatment Mini Percutaneous Nephrolithotomy and Flexible Ureteroscopy With Suction Sheath
不适用招募中EgyptNCT07306819A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
不适用招募中美国澳大利亚NCT06849258Bipolar Resection vs Enucleation of Prostate
不适用招募中EgyptNCT06983444Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?
II 期招募中中国NCT07625527Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer
II 期招募中中国NCT07475403Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer
III 期招募中意大利NCT07067749Safely Reduce Cystoscopic Evaluations for Hematuria Patients
不适用招募中荷兰NCT06026189Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients
不适用招募中中国台湾NCT05739968Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard Treatment
I 期 / II 期招募中美国NCT05126472Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
IV 期招募中美国NCT04305743Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
IV 期招募中丹麦Iceland挪威瑞典NCT06781879Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA
II 期招募中美国NCT06948552Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old
I 期招募中西班牙NCT06738576
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。